(Q48236931)

9 February 2018

title

Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. (English)

1 reference

9 February 2018

1 reference

Matthew R Cooperberg

4

0 references

author name string

Allison S Glass

1

1 reference

9 February 2018

Janet E Cowan

2

1 reference

9 February 2018

Mahesh J Fuldeore

3

1 reference

9 February 2018

Peter R Carroll

5

1 reference

9 February 2018

Stacey A Kenfield

6

1 reference

9 February 2018

Kirsten L Greene

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

21 May 2013

1 reference

9 February 2018

published in

Urology

1 reference

9 February 2018

volume

82

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

60-65

1 reference

9 February 2018

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Prostate cancer diagnosis, staging and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

EAU guidelines on prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Quality of life and satisfaction with outcome among prostate-cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Prediction of erectile function following treatment for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Who is the average patient presenting with prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Contemporary risk profile of prostate cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

NCCN clinical practice guidelines in oncology: prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.01.072

10.1016/J.UROLOGY.2013.01.072

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018